Get 20% lifetime commission for referring investors to digrin.com
here.
Vor Biopharma Inc. ( VOR) - Key Metrics
VOR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.16 | -$0.47 | -$0.47 |
| 2026Q1 | $0 | -$510.53 | -$88.92 | -$89.03 |
| 2025Q4 | $0 | $174.52 | -$2.31 | -$2.34 |
| 2025Q3 | $0 | -$121.63 | -$8.03 | -$8.07 |
| 2025Q2 | $0 | -$251.24 | -$5.62 | -$5.64 |
VOR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.97 |
| 2026Q1 | 0% | -0.01 |
| 2025Q4 | 0% | 0.01 |
| 2025Q3 | 0% | -0.10 |
| 2025Q2 | 0% | -0.03 |
VOR
Price: $23.01
52 week price:
Earnings Per Share: 171.01 USD
P/E Ratio: 0.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 63919
Market Capitalization: 1.2 billion